Multidrug-Resistant Bacterial Donor-Derived Infections in Solid Organ Transplantation.
Although rare, donor-derived infections (DDIs) caused by multidrug-resistant (MDR) bacteria can have devastating consequences for organ transplant recipients. Recognition of MDR bacterial DDIs can be challenging, as MDR bacteria are prevalent in most hospitals and distinguishing their transmission through transplantation from other, more typical routes of acquisition are difficult. New technologies such as whole genome sequencing have recently proven to be a powerful advance in the investigation of MDR bacterial DDIs. Once recognized, the optimal treatment of MDR bacterial DDIs is not clear. Herein, we review the clinical manifestations, outcomes, and management of MDR bacterial DDIs, and identify areas of uncertainty toward which the transplant community should direct further research efforts.
Division of Infectious Diseases & International Health, University of Virginia Health System, P.O. Box 800473, Charlottesville, VA, 22908-0473, USA.
Jessica D
JD
Lewis
Division of Infectious Diseases & International Health, University of Virginia Health System, P.O. Box 800473, Charlottesville, VA, 22908-0473, USA. csifri@virginia.edu.
Costi D
CD
Sifri
Donor-derived infections; Multidrug-resistant bacteria; Solid organ transplant